Previous 10 | Next 10 |
Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Influenza Multiplex PCR Test PR Newswire The clinical laboratory real-time PCR multiplex test was designed using Co-Dx Co-Primers™ and licensed by the CDSCO for use in diagnostic procedures ...
Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Webcast PR Newswire SALT LAKE CITY , Feb. 29, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for...
Co-Diagnostics, Inc. Shares List of Upcoming Industry Conferences and Events for February 2024 PR Newswire SALT LAKE CITY , Feb. 1, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a uniq...
Co-Diagnostics, Inc. to Host Booth at CES 2024 January 9-12 PR Newswire SALT LAKE CITY , Jan. 3, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the d...
2023-12-27 13:19:00 ET U.S. stocks on Wednesday made small moves , amid trading that is expected to be thin with many investors on holiday. Equities had kicked off the final week of the year on a positive note in the previous session. Here are some of Wednesday's biggest stock mover...
2023-12-27 11:50:29 ET More on Co-Diagnostics Co-Diagnostics, Inc. (CODX) Q3 2023 Earnings CallTranscript Co-Diagnostics Q3 2023 Earnings Preview Seeking Alpha’s Quant Rating on Co-Diagnostics Historical earnings data for Co-Diagnostics Financi...
Co-Diagnostics, Inc. Completes Submission to FDA for Co-Dx PCR Pro PR Newswire The Company's Emergency Use Authorization submission is for the new Co-Dx PCR Pro instrument and COVID-19 test kit, designed for point-of-care and at-home. The menu of tests in development for the...
Co-Diagnostics, Inc. to Participate in the Piper Sandler 35th Annual Healthcare Conference in New York City on November 30, 2023 PR Newswire SALT LAKE CITY , Nov. 29, 2023 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a mo...
2023-11-09 19:59:09 ET Co-Diagnostics, Inc. (CODX) Q3 2023 Earnings Conference Call November 9, 2023 4:30 PM ET Company Participants Andrew Benson - Head of Investor Relations Dwight Egan - Chief Executive Officer Brian Brown - Chief Financial Officer Confe...
2023-11-09 16:14:11 ET More on Co-Diagnostics Co-Diagnostics Q3 2023 Earnings Preview Seeking Alpha’s Quant Rating on Co-Diagnostics Historical earnings data for Co-Diagnostics Financial information for Co-Diagnostics For further details see: ...
News, Short Squeeze, Breakout and More Instantly...
Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast PR Newswire SALT LAKE CITY , April 25, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the developme...
Co-Diagnostics, Inc. to Host Booth and Deliver Presentation at APRC 2024 in Taiwan PR Newswire SALT LAKE CITY , April 24, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, pate...
Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event PR Newswire Ribbon-cutting included support from Mayor Wood of South Salt Lake and other dignitaries SALT LAKE CITY , April 12, 2024 /PRNewswire/ -- ...